Skip to main content
. 2019 Jun 18;69(684):e470–e478. doi: 10.3399/bjgp19X704321

Table 1.

Disease incidence according to inflammatory marker test results

Any relevant disease, n (%) Autoimmune disease, n (%) Infections, n (%) Cancer, n (%)
Untested (n= 37 539) 1293 (3.4) 200 (0.5) 760 (2.0) 354 (0.9)
Normal inflammatory markersa (n= 98 951) 5912 (6.0) 1652 (1.7) 2908 (2.9) 1503 (1.5)
Raised inflammatory markersb (n= 38 010) 5712 (15.0) 2121 (5.6) 2407 (6.3) 1407 (3.7)
Raised inflammatory markers, subdivided according to subsequent test results (n= 38 010) No subsequent inflammatory markers done (n= 27 874) 3471 (12.5) 1643 (5.9) 952 (3.4) 994 (3.6)
Subsequent inflammatory markers normal (n= 3314) 615 (18.6) 249 (7.5) 321 (9.7) 70 (2.1)
One or more raised inflammatory marker on subsequent testing (n= 6822) 1626 (23.8) 515 (7.6) 848 (12.4) 343 (5.0)
a

All inflammatory marker tests normal.

b

One or more inflammatory markers raised.